Business Context and Reporting Period
Company: Stepan Company
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2008
Business Overview: Stepan produces specialty and intermediate chemicals sold to manufacturers for use in detergents, personal care products, plastics, building materials, and food/pharmaceutical applications. The company operates three reportable segments: Surfactants (75% of 2008 sales), Polymers (22%), and Specialty Products (3%).
Key Financial Metrics (2008)
| Metric | 2008 Value | 2007 Value |
|---|---|---|
| Net Sales | $1,600.1 million | $1,329.9 million |
| Gross Profit | $169.5 million | $141.4 million |
| Operating Income | $70.7 million | $35.1 million |
| Net Income | $37.2 million | $15.1 million |
| Diluted EPS | $3.52 | $1.50 |
| Cash Flow from Operations | $29.1 million | $47.1 million |
| Total Debt | $143.0 million | $128.0 million |
| Working Capital | $116.3 million | $93.0 million |
| Capital Expenditures | $49.8 million | $39.8 million |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 20% ($270.2 million) driven primarily by higher average selling prices (recovering raw material costs) and favorable foreign currency translation. Sales volume declined 2% overall.
- Profitability Surge: Net income increased 146% to a record $37.2 million. Operating income rose 101%.
- Unusual Items: 2008 results included significant non-recurring gains:
- $9.9 million gain from the sale of commodity polyurethane systems product lines to Bayer.
- $8.5 million gain from the sale of 88 acres of land at the Millsdale facility.
- Segment Performance:
- Surfactants: Sales up 23%; Operating income up 76%.
- Polymers: Sales up 12%; Operating income up 22% (boosted by the product line sale gain).
- Specialty Products: Sales up 27%; Operating income flat.
- Cash Flow: Operating cash flow decreased to $29.1 million from $47.1 million in 2007 due to higher working capital demands driven by raw material inflation.
Guidance, Outlook, and Risks
- Outlook: Management expects the depth of the 2009 recession to affect sales volumes, particularly in polymer end-markets. The surfactant segment is viewed as relatively recession-resistant. Capital spending for 2009 is estimated at $45.0 to $50.0 million.
- Key Risks:
- Raw Material Volatility: Costs for petroleum-based materials and natural gas are cyclical and volatile; the company may not always be able to pass these costs to customers.
- Environmental Liabilities: The company is a potentially responsible party at 23 waste disposal sites. Accrued liability for environmental and legal losses was $16.7 million, with a possible range of $10.8 million to $34.4 million.
- Debt and Liquidity: Total debt increased to $143.0 million. The company maintains a $60 million revolving credit facility with $57.9 million available.
- Foreign Operations: 34% of sales are outside the U.S., exposing the company to currency fluctuations and foreign economic conditions.
- Accounting Changes: Adopted SFAS No. 159, electing the fair value option for mutual fund investments related to deferred compensation plans, resulting in $5.0 million of unrealized losses recorded in 2008 income.
Investor Verification Checklist
- Recurring Earnings: Verify core operating income excluding the $18.4 million in one-time gains (land and product line sales) to assess sustainable profitability.
- Working Capital Trends: Monitor accounts receivable and inventory levels, as inflationary pressures in 2008 significantly consumed cash flow.
- Environmental Reserves: Review the range of potential environmental liabilities ($10.8M - $34.4M) and the status of the Maywood, NJ site settlement.
- Debt Covenants: Confirm continued compliance with financial ratios required by the $60M revolving credit facility and term loans.
- 2009 Volume Exposure: Assess the impact of the global economic downturn on polymer sales volumes, which are more sensitive to recession than surfactants.